Get the Stockscreener App
11.66
1.35%
-0.16
After Hours:
11.66
Ocular Therapeutix Inc stock is traded at $11.66, with a volume of 2.64M.
It is down -1.35% in the last 24 hours and down -0.26% over the past month.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
See More
Previous Close:
$11.82
Open:
$11.81
24h Volume:
2.64M
Relative Volume:
0.99
Market Cap:
$2.03B
Revenue:
$61.10M
Net Income/Loss:
$-138.36M
P/E Ratio:
-8.637
EPS:
-1.35
Net Cash Flow:
$-90.59M
1W Performance:
+1.48%
1M Performance:
-0.26%
6M Performance:
+40.48%
1Y Performance:
+10.73%
1-Day Range:
$11.65
$12.07
1-Week Range:
$11.25
$12.10
52-Week Range:
$5.80
$13.85
Ocular Therapeutix Inc Stock (OCUL) Company Profile
Name
Ocular Therapeutix Inc
Sector
Industry
Phone
781-357-4000
Address
15 CROSBY DRIVE, BEDFORD, MA
Compare OCUL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCUL
Ocular Therapeutix Inc
|
11.66 | 2.50B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-15-25 | Initiated | Chardan Capital Markets | Buy |
| Apr-08-25 | Initiated | William Blair | Outperform |
| Mar-18-25 | Initiated | RBC Capital Mkts | Outperform |
| Mar-11-25 | Initiated | Needham | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jun-20-24 | Upgrade | TD Cowen | Hold → Buy |
| May-31-24 | Resumed | Piper Sandler | Overweight |
| Feb-09-24 | Initiated | BofA Securities | Buy |
| Apr-21-23 | Initiated | Robert W. Baird | Outperform |
| Aug-10-22 | Resumed | Berenberg | Buy |
| Aug-10-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-28-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-17-20 | Initiated | Berenberg | Buy |
| Nov-13-20 | Reiterated | Raymond James | Strong Buy |
| Aug-10-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-21-19 | Downgrade | Cowen | Outperform → Market Perform |
| May-21-19 | Reiterated | H.C. Wainwright | Buy |
| May-21-19 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-03-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-15-18 | Initiated | Raymond James | Strong Buy |
| Sep-07-18 | Initiated | Piper Jaffray | Overweight |
| Oct-24-17 | Initiated | Guggenheim | Buy |
| Jul-26-17 | Initiated | H.C. Wainwright | Buy |
| Jul-12-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Jun-23-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-10-17 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-15-16 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-11-16 | Initiated | JMP Securities | Mkt Outperform |
| Feb-17-16 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-23-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-13-15 | Initiated | Morgan Stanley | Overweight |
View All
Ocular Therapeutix Inc Stock (OCUL) Latest News
Multi asset correlation models including Ocular Therapeutix Inc.Market Performance Recap & Weekly Return Optimization Alerts - newser.com
Is Ocular Therapeutix Inc. stock oversold or undervalued2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
Short interest data insights for Ocular Therapeutix Inc.Trade Performance Summary & Community Verified Watchlist Alerts - newser.com
Will Ocular Therapeutix Inc. stock go up soon2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com
How to recover losses in Ocular Therapeutix Inc. stockJuly 2025 Sector Moves & Community Consensus Trade Alerts - newser.com
Why Ocular Therapeutix Inc. stock appeals to analystsEarnings Performance Report & Weekly Stock Performance Updates - newser.com
Is Ocular Therapeutix Inc. (0OT) stock positioned for digital growth eraWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Real time scanner hits for Ocular Therapeutix Inc. explained2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Can Ocular Therapeutix Inc. (0OT) stock beat analyst consensusJuly 2025 Update & AI Driven Stock Reports - newser.com
What institutional flow reveals about Ocular Therapeutix Inc.July 2025 Institutional & Verified Short-Term Plans - newser.com
Why analysts upgrade Ocular Therapeutix Inc. stockJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com
Ocular Therapeutix (NASDAQ:OCUL) Price Target Raised to $20.00 - MarketBeat
Ocular Therapeutix (OCUL) Projected to Post Earnings on Tuesday - MarketBeat
How Ocular Therapeutix Inc. (0OT) stock behaves in tightening cyclesQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Why Ocular Therapeutix Inc. (0OT) stock is trending on social mediaWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Is Ocular Therapeutix Inc. stock a buy in volatile marketsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Is this a good reentry point in Ocular Therapeutix Inc.Market Volume Summary & Long Hold Capital Preservation Tips - newser.com
Using Ichimoku Cloud for Ocular Therapeutix Inc. technicalsMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for Ocular Therapeutix Inc.Layoff News & Verified Momentum Stock Alerts - newser.com
Can Ocular Therapeutix Inc. hit a new high this monthMarket Growth Summary & Reliable Breakout Stock Forecasts - newser.com
Is Ocular Therapeutix Inc. stock undervalued vs historical averages2025 Trade Ideas & AI Based Buy/Sell Signal Reports - newser.com
How Ocular Therapeutix Inc. (0OT) stock responds to job market shifts - newser.com
Ocular Therapeutix (OCUL): TD Cowen Raises Price Target, Reaffir - GuruFocus
Wall Street Analysts Believe Ocular Therapeutix (OCUL) Could Rally 82.93%: Here's is How to Trade - sharewise.com
Ocular Therapeutix Inc Stock (OCUL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):